FACT-MNG

Tumor site specific web-based outcome instrument for meningioma patients

D. Zlotnick, S. N. Kalkanis, A. Quinones-Hinojosa, K. Chung, M. E. Linskey, R. L. Jensen, F. Demonte, F. G. Barker, C. A. Racine, M. S. Berger, P. M. Black, M. Cusimano, L. N. Sekhar, A. Parsa, M. Aghi, Michael W. McDermott

Research output: Contribution to journalArticle

Abstract

To formulate Functional Assessment of Cancer Therapy-Meningioma (FACT-MNG), a web-based tumor site-specific outcome instrument for assessing intracranial meningioma patients following surgical resection or stereotactic radiosurgery. We surveyed the relevant literature available on intracranial meningioma surgery and subsequent outcomes (38 papers), making note of which, if any, QOL/outcome instruments were utilized. None of the surgveyed papers included QOL assessment specific to tumor site. We subsequently developed questions that were relevant to the signs and symptoms that characterize each of 11 intracranial meningioma sites, and incorporated them into a modified combination of the Functional Assessment of Cancer Therapy-Brain (FACT-BR) and SF36 outcome instruments, thereby creating a new tumor site-specific outcome instrument, FACT-MNG. With outcomes analysis of surgical and radiosurgical treatments becoming more important, measures of the adequacy and success of treatment are needed. FACT-MNG represents a first effort to formalize such an instrument for meningioma patients. Questions specific to tumor site will allow surgeons to better assess specific quality of life issues not addressed in the past by more general questionnaires.

Original languageEnglish (US)
Pages (from-to)423-431
Number of pages9
JournalJournal of Neuro-Oncology
Volume99
Issue number3
DOIs
StatePublished - Sep 2010

Fingerprint

Meningioma
Neoplasms
Therapeutics
Radiosurgery
Brain Neoplasms
Signs and Symptoms
Quality of Life

Keywords

  • Intracranial surgery
  • Meningioma
  • Quality of life
  • Radiotherapy

ASJC Scopus subject areas

  • Clinical Neurology
  • Cancer Research
  • Oncology
  • Neurology

Cite this

Zlotnick, D., Kalkanis, S. N., Quinones-Hinojosa, A., Chung, K., Linskey, M. E., Jensen, R. L., ... McDermott, M. W. (2010). FACT-MNG: Tumor site specific web-based outcome instrument for meningioma patients. Journal of Neuro-Oncology, 99(3), 423-431. https://doi.org/10.1007/s11060-010-0394-3

FACT-MNG : Tumor site specific web-based outcome instrument for meningioma patients. / Zlotnick, D.; Kalkanis, S. N.; Quinones-Hinojosa, A.; Chung, K.; Linskey, M. E.; Jensen, R. L.; Demonte, F.; Barker, F. G.; Racine, C. A.; Berger, M. S.; Black, P. M.; Cusimano, M.; Sekhar, L. N.; Parsa, A.; Aghi, M.; McDermott, Michael W.

In: Journal of Neuro-Oncology, Vol. 99, No. 3, 09.2010, p. 423-431.

Research output: Contribution to journalArticle

Zlotnick, D, Kalkanis, SN, Quinones-Hinojosa, A, Chung, K, Linskey, ME, Jensen, RL, Demonte, F, Barker, FG, Racine, CA, Berger, MS, Black, PM, Cusimano, M, Sekhar, LN, Parsa, A, Aghi, M & McDermott, MW 2010, 'FACT-MNG: Tumor site specific web-based outcome instrument for meningioma patients', Journal of Neuro-Oncology, vol. 99, no. 3, pp. 423-431. https://doi.org/10.1007/s11060-010-0394-3
Zlotnick D, Kalkanis SN, Quinones-Hinojosa A, Chung K, Linskey ME, Jensen RL et al. FACT-MNG: Tumor site specific web-based outcome instrument for meningioma patients. Journal of Neuro-Oncology. 2010 Sep;99(3):423-431. https://doi.org/10.1007/s11060-010-0394-3
Zlotnick, D. ; Kalkanis, S. N. ; Quinones-Hinojosa, A. ; Chung, K. ; Linskey, M. E. ; Jensen, R. L. ; Demonte, F. ; Barker, F. G. ; Racine, C. A. ; Berger, M. S. ; Black, P. M. ; Cusimano, M. ; Sekhar, L. N. ; Parsa, A. ; Aghi, M. ; McDermott, Michael W. / FACT-MNG : Tumor site specific web-based outcome instrument for meningioma patients. In: Journal of Neuro-Oncology. 2010 ; Vol. 99, No. 3. pp. 423-431.
@article{536a8dfd67fa45469324218c4a3b201b,
title = "FACT-MNG: Tumor site specific web-based outcome instrument for meningioma patients",
abstract = "To formulate Functional Assessment of Cancer Therapy-Meningioma (FACT-MNG), a web-based tumor site-specific outcome instrument for assessing intracranial meningioma patients following surgical resection or stereotactic radiosurgery. We surveyed the relevant literature available on intracranial meningioma surgery and subsequent outcomes (38 papers), making note of which, if any, QOL/outcome instruments were utilized. None of the surgveyed papers included QOL assessment specific to tumor site. We subsequently developed questions that were relevant to the signs and symptoms that characterize each of 11 intracranial meningioma sites, and incorporated them into a modified combination of the Functional Assessment of Cancer Therapy-Brain (FACT-BR) and SF36 outcome instruments, thereby creating a new tumor site-specific outcome instrument, FACT-MNG. With outcomes analysis of surgical and radiosurgical treatments becoming more important, measures of the adequacy and success of treatment are needed. FACT-MNG represents a first effort to formalize such an instrument for meningioma patients. Questions specific to tumor site will allow surgeons to better assess specific quality of life issues not addressed in the past by more general questionnaires.",
keywords = "Intracranial surgery, Meningioma, Quality of life, Radiotherapy",
author = "D. Zlotnick and Kalkanis, {S. N.} and A. Quinones-Hinojosa and K. Chung and Linskey, {M. E.} and Jensen, {R. L.} and F. Demonte and Barker, {F. G.} and Racine, {C. A.} and Berger, {M. S.} and Black, {P. M.} and M. Cusimano and Sekhar, {L. N.} and A. Parsa and M. Aghi and McDermott, {Michael W.}",
year = "2010",
month = "9",
doi = "10.1007/s11060-010-0394-3",
language = "English (US)",
volume = "99",
pages = "423--431",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",
number = "3",

}

TY - JOUR

T1 - FACT-MNG

T2 - Tumor site specific web-based outcome instrument for meningioma patients

AU - Zlotnick, D.

AU - Kalkanis, S. N.

AU - Quinones-Hinojosa, A.

AU - Chung, K.

AU - Linskey, M. E.

AU - Jensen, R. L.

AU - Demonte, F.

AU - Barker, F. G.

AU - Racine, C. A.

AU - Berger, M. S.

AU - Black, P. M.

AU - Cusimano, M.

AU - Sekhar, L. N.

AU - Parsa, A.

AU - Aghi, M.

AU - McDermott, Michael W.

PY - 2010/9

Y1 - 2010/9

N2 - To formulate Functional Assessment of Cancer Therapy-Meningioma (FACT-MNG), a web-based tumor site-specific outcome instrument for assessing intracranial meningioma patients following surgical resection or stereotactic radiosurgery. We surveyed the relevant literature available on intracranial meningioma surgery and subsequent outcomes (38 papers), making note of which, if any, QOL/outcome instruments were utilized. None of the surgveyed papers included QOL assessment specific to tumor site. We subsequently developed questions that were relevant to the signs and symptoms that characterize each of 11 intracranial meningioma sites, and incorporated them into a modified combination of the Functional Assessment of Cancer Therapy-Brain (FACT-BR) and SF36 outcome instruments, thereby creating a new tumor site-specific outcome instrument, FACT-MNG. With outcomes analysis of surgical and radiosurgical treatments becoming more important, measures of the adequacy and success of treatment are needed. FACT-MNG represents a first effort to formalize such an instrument for meningioma patients. Questions specific to tumor site will allow surgeons to better assess specific quality of life issues not addressed in the past by more general questionnaires.

AB - To formulate Functional Assessment of Cancer Therapy-Meningioma (FACT-MNG), a web-based tumor site-specific outcome instrument for assessing intracranial meningioma patients following surgical resection or stereotactic radiosurgery. We surveyed the relevant literature available on intracranial meningioma surgery and subsequent outcomes (38 papers), making note of which, if any, QOL/outcome instruments were utilized. None of the surgveyed papers included QOL assessment specific to tumor site. We subsequently developed questions that were relevant to the signs and symptoms that characterize each of 11 intracranial meningioma sites, and incorporated them into a modified combination of the Functional Assessment of Cancer Therapy-Brain (FACT-BR) and SF36 outcome instruments, thereby creating a new tumor site-specific outcome instrument, FACT-MNG. With outcomes analysis of surgical and radiosurgical treatments becoming more important, measures of the adequacy and success of treatment are needed. FACT-MNG represents a first effort to formalize such an instrument for meningioma patients. Questions specific to tumor site will allow surgeons to better assess specific quality of life issues not addressed in the past by more general questionnaires.

KW - Intracranial surgery

KW - Meningioma

KW - Quality of life

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=77957606213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957606213&partnerID=8YFLogxK

U2 - 10.1007/s11060-010-0394-3

DO - 10.1007/s11060-010-0394-3

M3 - Article

VL - 99

SP - 423

EP - 431

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 3

ER -